Zimmer Biomet CPT Hip System and Periprosthetic Femoral Fractures

The Zimmer Biomet CPT Hip System is a widely used medical device designed to help patients undergoing hip replacement surgery. However, recent concerns have emerged regarding its safety, with reports of postoperative complications and increased risks of thigh bone fractures. If you or a loved one have had a CPT Hip System implanted, it’s crucial to understand the potential dangers and your legal rights.

What is the Zimmer Biomet CPT Hip System?

The Zimmer Biomet CPT Hip System is a femoral stem used in hip replacement surgeries. It has been commonly implanted in patients to restore hip function, particularly in those suffering from arthritis or other degenerative joint diseases. This particular system features a polished-taper slip (PTS) style stem, which is made from cobalt chromium alloy and is designed to help with the long-term performance of the artificial joint.

Despite its widespread use, recent data has raised significant concerns about the safety and long-term effects of this device.

Recent Dangers of the CPT Hip System Including Periprosthetic Femoral Fractures

In July 2024, Zimmer Biomet initiated a voluntary recall to update the instructions for use for the CPT Hip System due to an increased risk of thigh bone fractures after surgery. Known as postoperative periprosthetic femoral fractures, these complications can result in severe pain, mobility issues, and often require additional surgery to correct.

Research conducted by both the U.S. Food and Drug Administration (FDA) and international regulatory bodies, such as the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK, found that the Zimmer Biomet CPT Hip System posed a higher risk of thigh bone fractures compared to other similar hip replacement devices. According to the data, patients implanted with the CPT Hip System have approximately a 1.4% chance of experiencing these fractures, which is significantly higher than the rates seen with other devices (which range from 0.6% to 1%).

FDA Actions and Recommendations

The FDA has expressed concerns about the continued use of the Zimmer Biomet CPT Hip System, especially given the increased risk of fractures and the potential need for corrective surgery. While Zimmer Biomet plans to phase out the sale of this device by December 2024, the FDA has urged healthcare providers to consider alternative hip replacement devices when possible. 

If you already have the CPT Hip System and are not experiencing any unusual symptoms, the FDA does not recommend removing the implant. However, patients experiencing unexplained pain or difficulty walking should seek immediate medical attention.

KBA Attorneys Is Investigating the Zimmer Biomet CPT Hip System and Periprosthetic Femoral Fractures

If you or someone you know has experienced complications following surgery with the Zimmer Biomet CPT Hip System, you may be entitled to legal compensation. KBA Attorneys is actively investigating claims related to this device. Patients who have suffered from thigh bone fractures or required revision surgery after receiving the CPT Hip System may have grounds for a lawsuit.

For more information on the Zimmer Biomet CPT Hip System, check out our recent blogs about the system:

Fractured Femur Zimmer Biomet CPT Hip Implant

KBA Attorneys is dedicated to ensuring that the manufacturers of defective medical devices are held accountable for the harm caused to patients. If you believe you have been affected by the Zimmer Biomet CPT Hip System, contact us to learn more about your legal options and how they can help you pursue justice.

Read More About Zimmer Biomet

We have posted two blogs about this product.

Fractured Femur Zimmer Biomet CPT Hip Implant

Risk of Periprosthetic Femoral Fractures in Zimmer Biomet Hip